Give now

News

  • October 22, 2020
    LLNL develops first-ever living, 3D-bioprinted aneurysm to test surgical treatments
    Learn more
  • August 04, 2020
    Stryker’s Neuroform Atlas Stent System granted an expanded indication
    Learn more
  • August 04, 2020
    After a brain aneurysm rupture, can a delayed cerebral ischemia (DCI) be stopped?
    Learn more
  • May 22, 2020
    Neurosurgeons outline reassuring facts and innovative treatment advances
    Learn more
  • February 22, 2020
    Doctors Use Robotics to Treat Brain Aneurysm
    Learn more
  • January 31, 2020
    Why medical polymers are paving the way for more efficient technologies
    Learn more
  • January 23, 2020
    Can Artificial Intelligence be used to Diagnose Brain Aneurysms?
    Learn more
  • January 10, 2020
    2018 Research Grant Recipient developing biomaterial for treatment of aneurysms
    Learn more
  • December 10, 2019
    Machine Algorithm Accurately Detects Seizure Risks
    Learn more

In My Area

Support groups
  • AdventHealth Brain Aneurysm Support Group

    Winter Park, FL

    Learn more
  • Baltimore Brain Aneurysm Foundation Support Group

    Lutherville-Timonium, MD

    Learn more
  • Bay Area Aneurysm and Vascular Malformation Support Group

    San Francisco, CA

    Learn more
  • January 31, 2020
  • BAF
  • Technology

Why medical polymers are paving the way for more efficient technologies

In the current scenario, chronic medical ailments like cardiovascular issues, infections, generic medical conditions, and other disorders are becoming increasingly prevalent. This in turn is necessitating the development of advanced pharmaceutical devices and sophisticated medical treatments.

One of the most commonly utilised materials for medical applications is polymers. Natural polymers like hair, horn and cellulose have been used for many years by humans for a multitude of purposes including medical, for instance – suture materials.

The modern, man-made or synthetic medical polymers used today, began to develop somewhere around the Second World War period, and have demonstrated a robust potential in the pharmaceutical industry. This potential is attributed to their many beneficial chemical and physical properties including permeability, flexibility and mechanical self-reinforcement, among others.

The global medical polymers market is witnessing strong growth in current years and it is expected that these materials will replace the conventional ceramic, glass and metal-based equipment and implants in the years ahead.

Proliferating cases of cerebral aneurysms
The Brain Aneurysm Foundation has estimated that nearly 6.5 million people in the United States have cerebral aneurysms that are unruptured. It is expected that around 30,000 individuals will face an aneurysm rupture each year, with nearly 15% patients succumbing before they receive medical care, 25% deaths occurring despite medical attention and only one in four expected to make a full recovery.

In light of these alarming statistics, a team at the Department of Mechanical Engineering in North Arizona University is working on developing a new polymer designed to restrict the growth and rupture of aneurysms. The polypropylene glycol-based biomaterial, dubbed PPODA-QT is very similar to body tissue, and is built to restrict the growth of aneurysms in the brain, in turn enhancing patient outcomes in stroke and potential stroke patients.

Read the full story here

by Hrishikesh Kadam



This site uses cookies

Our site uses cookies to personalize features and, via third-parties, to collect metrics on usage so that we can better tailor our site to the needs of our users. You can view our full cookie and privacy policies via the links below. To fully experience our site, please click Accept.